The acquisition will expand Zydus' presence in the healthy snacking market. Naturell had annual revenues of Rs129 crore in FY24. The deal is expected to boost Zydus' earnings from the next year ...
Zydus received FDA approval to conduct a Phase 2b trial testing usnoflast, its oral therapy for ALS, in 210 patients.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback